Phase 1 Pulmonary Arterial Hypertension PAH Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study of Intravenous ZMA001 in Healthy Subjects

Pulmonary Arterial Hypertension PAH

National Heart, Lung, and Blood Institute (NHLBI)96 enrolled1 locationNCT05967299

Recruiting

Phase 1Phase 2

A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Pulmonary Arterial Hypertension PAH

ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.120 enrolled32 locationsNCT07593027

Recruiting

Phase 1

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension PAH

Joseph C. Wu15 enrolled1 locationNCT06872112